Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
On #WorldHeartDay, let us pledge to adopt healthy lifestyles to live a heart-healthy life.
Make the right decisions, act with courage and help others in learning to manage cardiovascular diseases. I urge everyone to lead an active lifestyle to keep heart healthy.
Dr. Mansukh Mandaviya
Minister of Health and Family Welfare;
Chemicals and Fertilizers,
Govt. of India
Sponsor
Patient Safety Capsules
Parliamentary panel asks govt to start RLI scheme to promote R&D and innovation
New Delhi, September 27, 2022: The Department-Related Parliamentary Standing Committee on ministry of health and family welfare has suggested to the Ministry to start Research Linked Incentive (RLI) scheme in line with the production linked incentive (PLI) scheme in order to promote research and development and innovation in the segment. The PLI scheme should also be broad based to include all medical devices, it added.
Centre changes name of SCAMPH to CAMPH, adds DoP, NPPA representatives to the Committee
New Delhi, September 27, 2022: The ministry of chemicals and fertilisers has changed the name of the Standing Committee on Affordable Medicines and Health Products (SCAMPH), the recommending body to National Pharmaceutical Pricing Authority (NPPA) formed through an order on January 21, 2019, to Committee on Affordable Medicines and Health Products (CAMPH)
Drug Laws & Policy Injections
Drug industry welcomes National Logistics Policy to bring down logistics cost to single digit levelMumbai, September 24, 2022: The drug industry has welcomed the National Logistics Policy (NLP) launched by the Union government aiming to reduce the cost of logistics to single digit levels from 13-14 per cent of the gross domestics (DGP) product of the country.
ICMR releases draft ethical guidelines for adoption of AI in biomedical research and healthcare Mumbai, September 27, 2022: The Indian Council of Medical Research (ICMR) has released draft ethical guidelines for application of artificial intelligence in biomedical research and healthcare.
Panel asks govt to submit response from five state govts on strengthening drug regulatory mechanismNew Delhi, September 28, 2022: The Department-Related Parliamentary Standing Committee for ministry of health and family welfare has sought the Centre to submit the response from the five states including Maharashtra, Uttar Pradesh, among others on the proposed project proposals for strengthening their state drug regulatory system.
Global drug regulators at iPHEX show willingness to forge mutual recognition of regulatory approvals, pharmacopoeiasMumbai, September 28, 2022: Drug regulators from more than 70 countries, converged at the 8th edition of iPHEX, have shown willingness to forge mutual recognition agreements in regulation of medicines which will allow faster regulatory approval thus improving availability and accessibility of pharmaceutical products.
Govt adds 34 drugs to essential medicines listNew Delhi, September 17, 2022: The Union health ministry on Tuesday added 34 new drugs to the National List of Essential Medicines (NLEM) 2022. The medicines have been categorised into 27 therapeutic categories with more anti-cancer, antibiotics and vaccines being added to the list, making them more affordable.
Parliamentary panel recommends govt appeals to nations to identify Covid origin, penalise culpritsNew Delhi, September 15, 2022: A parliamentary committee has recommended the government appeals to the comity of nations to conduct more studies to identify the origin of COVID-19 and penalise the culprits at an international platform.
Pharma Injections
Indian medical associations deny shortage of GeneXpert TB testsMumbai, September 26, 2022: Close on the heels of MSF raising concern over delays in supply of GeneXpert TB tests by the US Corporation Cepheid affecting national TB programmes in low-and middle-income countries, Indian medical associations have maintained that there is hardly any shortage of GeneXpert TB tests in the country.
Pharma imports decline 2.84% in AugustNew Delhi, September 24, 2022: The imports of pharmaceutical products during the month of August have reported a decline of around three per cent to $638.23 million, as compared to $656.88 million during the same period of previous year.
Delhi HC quashes NPPA orders on overcharging against Bharat Serums and Vac-cines and Bard Healthcare New Delhi, September 24, 2022: The Delhi High Court has quashed four demand notices raised by the National Pharmaceutical Pricing Authority (NPPA) against Bharat Serums and Vaccines Ltd and medical devices manufacturer Bard Healthcare India Pvt Ltd for overcharging on non-scheduled drugs and medical devices,
AIDCOC reminds AP PSC of annulment of recruitment of drug inspectors by various PSCs for not adhering to Rule 49 Chennai, September 26, 2022: The All India Drug Control Officers Confederation (AIDCOC) has reminded the public services commission (PSC) of Arunachal Pradesh that the recruitment agency is bound to comply with the provisions of the Drugs and Cosmetics (D&C) Act while recruiting drug inspectors for the health and family welfare department under the government.
Need to fast-track regulatory processes for biotech sector: Report September 23, 2022: There is a need to fast-track regulatory processes and repeal redundant steps to fasten the approval process for the biotech industry as any delay in product introduction leads to huge losses for the sector, according to a report by industry body CII.
Government forms committee to regulate marketing practices of pharma companies New Delhi, September 21, 2022: The government has constituted a high-level committee to hammer out a legal mechanism to address the issue of pharmaceutical companies giving inducements for promoting their drugs and products.
Drug Dopes
CPCSEA recommends conducting IAEC meetings through hybrid mode to expedite processNew Delhi, September 28, 2022: In an effort to expedite the functioning of Institutional Animal Ethics Committees (IAECs) as part of expediting the drug research and approval processes, the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) has recommended that the IAEC meetings should be conducted through hybrid mode if required. 
CPCSEA recommends use of stray dogs for new vaccine trials and challenge studies of vaccinesNew Delhi, September 26, 2022: The Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) under the ministry of fisheries, animal husbandry and dairying, has recommended that stray dogs may be used for new vaccine trials and challenge studies of vaccines subject to adhering the guidelines of the Committee.
Big Data lowers prescription errors, IoT enables transparency in medical insurance claims: Raghav Kini Bengaluru, September 24, 2022: Indian healthcare sees digital transformation as an indispensable development in the industry. This is driven by the patient-centric approach to healthcare where accurate diagnosis and treatment are the need of the hour.
Pharma supply chain impacted by low tech innovation and lack of transparency: Akshay Hegde Bengaluru, September 27, 2022: Pharma supply chain is impacted by low technology innovation and lack of transparency. Considering India’s importance in the global supply chain, the country has to overcome challenges in quality and regulatory issues, product proliferation, supply chain fragmentation, and incompetent infrastructure, said Akshay Hegde, co-founder of ShakeDeal.
India’s under 5 mortality rate sees 3-point decline; UP, Karnataka record highest dip: Report New Delhi, September 23, 2022: India’s under 5 mortality rate has significantly declined by from 35 per 1,000 live births in 2019 to 32 per 1,000 live births in 2020, with the highest decline recorded in Uttar Pradesh and Karnataka, according to the Sample Registration System (SRS) Statistical Report 2020.
9.5 lakh tuberculosis patients adopted under ‘Pradhan Mantri TB Mukt Bharat Abhiyan’September 17, 2022: Over 9.5 lakh tuberculosis patients have been adopted under the ‘Pradhan Mantri TB Mukt Bharat Abhiyan’ which was launched by President Droupadi Murmu on September 9 with an aim to eliminate the disease five years ahead of the SDG (Sustainable Development Goal) target of 2030.
National Injections
ARDSI urges Karnataka govt to make dementia a health priority Bengaluru, September 26, 2022: The Alzheimer’s & Related Disorders Society of India (ARDSI) has urged the Karnataka government to make dementia a health priority as changes in brain are evident in the ageing population. In this regard, the Society has submitted a memorandum to the state government indicating that the disease is impacting the elderly and is an irreversible condition if interventions are not made.
Over 500 chemists in Kerala to take oath on WPD day pledging abstinence from sale of habit-forming drugsChennai, September 24, 2022: The members of the All Kerala Chemists and Druggists Association (AKCDA) in Thiruvananthapuram district will take a solemn oath along with students of pharmaceutical sciences and their teachers on September 25, as part of the institution’s World Pharmacist Day celebration.
AKCDA assures full support to Kerala govt for its mission to eradicate narcotic substances from the state Chennai, September 27, 2022: Supporting the government’s efforts to tackle the drug menace in the state, the pharmaceutical traders under the All Kerala Chemists and Druggists Association (AKCDA) took one pledge in the presence of a state minister and the drug control authorities that they would neither deal in narcotic substances nor let others sell any kind of unwanted intoxicant directly or indirectly to anyone.
Delhi reports fresh case of Monkeypox! Nigerian woman tests positive New Delhi, September 16, 2022: The monkeypox case tally in India has reached 13 after a 30-year-old Nigerian woman in Delhi reportedly tested positive. This is the 8th case of the viral infection in the national capital, the PTI reported quoting sources on Friday. The woman has been admitted to Lok Nayak Jai Prakash Narayan Hospital (LNJP), they added.
Lancet report on unapproved antibiotic use in India is ‘misleading, inappropriate’: Govt official New Delhi, September 14, 2022: A Health Ministry official has dismissed as “misleading and inappropriate” a Lancet report claiming that more than 47 per cent of antibiotic formulations used in India’s private sector in 2019 were unapproved.
Indigenous vaccine to help curb disease in cattle: PM Narendra Modi September 13, 2022: Prime Minister Narendra Modi on Monday said that scientists have developed an indigenous vaccine for lumpy skin disease (LSD), which has so far spread across 11 states. “Development of the indigenous vaccine for LSD and its quick spread across India, and efforts to control the movement of cattle from one state to another are the steps being taken to control LSD,”
Global Injections
FDA to Explore Nutrition Labels on Front of PackagesSeptember 28, 2022: The Biden administration is pushing to change nutrition labels on food packaging to help people eat better and to encourage manufacturers to make healthier products.
CDC: Masking No Longer Required in Health Care SettingsSeptember 28, 2022: The Centers for Disease Control has changed its position on mandatory masking in health care settings, no longer recommending that it be universal.
COVID Vaccine Linked to Temporary Change in Menstrual Cycle: Study
September 28, 2022: Some people who have received a COVID-19 vaccine have reported a temporary change in their men-strual cycles, according to a new study published in BMJ Medicine.
Cancer-killing virus shows promise in patients
Sepetember 23, 2022: A new type of cancer therapy that uses a common virus to infect and destroy harmful cells is showing big promise in early human trials, say UK scientists.
'Truly remarkable' drug helps motor neurone disease
September 21, 2022: The treatment works in only 2% of patients but has been described as "truly remarkable" and a "real mo-ment of hope" for the whole disease.
Merck inks deal with Sinopharm to commercialize COVID-19 pills in China
September 28, 2022: A month ago, Zhejiang Huahai revealed a five-year deal to produce and sell Pfizer’s COVID-19 oral anti-viral Paxlovid exclusively in China.
PSAIIF PILL
Upgradation of existing WHO-GMP plant for higher standards not included under PTUAS: DoP
New Delhi, September 29, 2022: Even as any pharma Micro, Small and Medium Enterprise (MSME) unit with proven track record to upgrade technology to meet World Health Organisation's Good Manufacturing Practice (WHO-GMP) or Schedule M Standards can apply under the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS), upgradation of existing WHO-GMP plant for higher standards of WHO-GMP or EU GMP or US FDA is not included in the eligibility criteria at present, clarifies the Department of Pharmaceuticals (DoP).
Industry pins hope on govt panel to streamline regulations governing marketing practices
Mumbai, September 29, 2022: Drug manufacturers have expressed hope that a high-level committee formed by the government to review their marketing practices will suggest ways to fill the gap in the lack of specific regulation in India that governs how businesses can advertise and market their products to healthcare professionals (HCPs).
Frequently Asked Questions
Altitude sickness: Protective measures
A few days ago I decided to break the monotony of life inspired by the other wilderness travellers in my circle of friends and went on backpacking. Although I have been a frequent traveller from much before, this was my first ever expedition to “the Hi-malayas” (Tarsar & Marsar, Kashmir). The team consisted majorly of doctors from different specialities, business entrepreneurs and advocates etc. This was organized by “Mr Tiger Solanki’ and ‘Pahadi Adventures’. Read More>>>
SUBSCRIBER'S SYMPTOM
More than a gut feeling: How microbes are a necessity in our health
September 25, 2022: Did you know that up to 90% of the human body is made of trillions of microorganisms such as bacteria, virus, fungi and archaea—so much so that we have more microbes than cells? The very thought of bacteria or virus in the gut may sound dreadful but the fact is that these microbes—a majority of which live in our gut, particularly in the large intestine—are a necessity for our health.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Dr Vivek Parikh, MD "The Prescription" helps give me my monthly dose of current pharma news which I eagerly look forward to in order to keep myself abreast as a more aware reader. Keep up the good work.
Ms Supriya Singh, ProfessionalWant to commend the PSAII India publication team for all the good work they do in bringing out this bi-monthly newsletter. Well done.
Mr Ramamurthy Iyer, Pharma Expert
Very beautifully and aptly captures important news in the Pharma domain. Excellent work.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
